Top Markets
Coin of the day
Axcella Health Inc. Axcella Health Inc.

Axcella Health Inc.

AXLA
Classifica tra le azioni #18693
Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused... Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused on developing novel therapeutic compositions derived from endogenous metabolic modulators. These aim to address complex diseases and improve overall health. The company's primary drug candidates are AXA1665 and AXA1125. AXA1665 is currently undergoing Phase 2 clinical trials, where it is being evaluated for its potential to lower the risk of recurrent overt hepatic encephalopathy. Meanwhile, AXA1125 is progressing through multiple trials: a Phase 2b study targeting non-alcoholic steatohepatitis (NASH) treatment, and a Phase 2a study exploring its efficacy as a therapy for Long COVID patients. Founded in 2008, the entity initially operated as Newco LS16, Inc. before officially adopting the name Axcella Health Inc. in June 2016. Its operations are headquartered in Cambridge, Massachusetts.
Prezzo delle azioni
$4.58
Ultima sincronizzazione: 2025-02-06
Capitalizzazione di mercato
$189.73M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Axcella Health Inc. (AXLA)

Categoria

Storico del prezzo dell'azione per Axcella Health Inc. (AXLA)
Prezzo di chiusura più alto: $4.58 il 2025-02-01

Prezzo di chiusura più basso: $350.75 il 2019-05-01
Storico del prezzo dell'azione di Axcella Health Inc. dal 2019 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2025 0.00%
2024 512.21%
2023 -94.99%
2022 -75.57%
2021 -55.79%
2020 46.98%
2019 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$549.38 41.89%
US
$1.05K 47.72%
NL
$148.35 499.86%
US
$121.62 -12.98%
AU
$764.47 6.25%
CH